

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | snRNA metabolic process (GO:0016073) | 9.25223855 |
| 2 | protein K11-linked deubiquitination (GO:0035871) | 9.06203307 |
| 3 | peptidyl-threonine dephosphorylation (GO:0035970) | 8.07774971 |
| 4 | regulation of MHC class II biosynthetic process (GO:0045346) | 7.55249849 |
| 5 | mitochondrion degradation (GO:0000422) | 7.47848203 |
| 6 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 7.42411393 |
| 7 | histone H3-K4 trimethylation (GO:0080182) | 7.36248366 |
| 8 | rRNA catabolic process (GO:0016075) | 6.86652701 |
| 9 | interferon-gamma production (GO:0032609) | 5.91124377 |
| 10 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 5.79891342 |
| 11 | N-acetylneuraminate metabolic process (GO:0006054) | 5.68019172 |
| 12 | vesicle targeting (GO:0006903) | 5.53786847 |
| 13 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 5.21519482 |
| 14 | interleukin-6-mediated signaling pathway (GO:0070102) | 5.19435210 |
| 15 | reciprocal DNA recombination (GO:0035825) | 5.14947355 |
| 16 | reciprocal meiotic recombination (GO:0007131) | 5.14947355 |
| 17 | acrosome assembly (GO:0001675) | 5.10373159 |
| 18 | C-terminal protein lipidation (GO:0006501) | 5.08312179 |
| 19 | auditory receptor cell stereocilium organization (GO:0060088) | 4.99225986 |
| 20 | mismatch repair (GO:0006298) | 4.90578187 |
| 21 | carnitine metabolic process (GO:0009437) | 4.90096656 |
| 22 | fucose catabolic process (GO:0019317) | 4.87327163 |
| 23 | L-fucose metabolic process (GO:0042354) | 4.87327163 |
| 24 | L-fucose catabolic process (GO:0042355) | 4.87327163 |
| 25 | cellular response to exogenous dsRNA (GO:0071360) | 4.80805795 |
| 26 | negative regulation of type I interferon production (GO:0032480) | 4.63791085 |
| 27 | regulation of triglyceride biosynthetic process (GO:0010866) | 4.60630777 |
| 28 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 4.58987468 |
| 29 | inner ear receptor stereocilium organization (GO:0060122) | 4.54870663 |
| 30 | positive regulation of defense response to virus by host (GO:0002230) | 4.50105306 |
| 31 | interkinetic nuclear migration (GO:0022027) | 4.40638703 |
| 32 | positive regulation of histone H3-K4 methylation (GO:0051571) | 4.40265098 |
| 33 | C-terminal protein amino acid modification (GO:0018410) | 4.30209028 |
| 34 | positive regulation of cytokinesis (GO:0032467) | 4.28453745 |
| 35 | peptidyl-lysine trimethylation (GO:0018023) | 4.25813508 |
| 36 | kynurenine metabolic process (GO:0070189) | 4.18278211 |
| 37 | granulocyte differentiation (GO:0030851) | 4.17242903 |
| 38 | female gamete generation (GO:0007292) | 4.16559891 |
| 39 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 4.04344380 |
| 40 | regulation of fatty acid oxidation (GO:0046320) | 4.01511268 |
| 41 | negative regulation of interleukin-8 production (GO:0032717) | 4.01116015 |
| 42 | negative regulation of NF-kappaB import into nucleus (GO:0042347) | 3.99901783 |
| 43 | indole-containing compound catabolic process (GO:0042436) | 3.95607264 |
| 44 | indolalkylamine catabolic process (GO:0046218) | 3.95607264 |
| 45 | tryptophan catabolic process (GO:0006569) | 3.95607264 |
| 46 | negative regulation of defense response to virus (GO:0050687) | 3.90353430 |
| 47 | ncRNA catabolic process (GO:0034661) | 3.85142349 |
| 48 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 3.85093084 |
| 49 | positive regulation of mitochondrial fission (GO:0090141) | 3.81505680 |
| 50 | nerve growth factor signaling pathway (GO:0038180) | 3.74370412 |
| 51 | regulation of memory T cell differentiation (GO:0043380) | 3.74087543 |
| 52 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.73910897 |
| 53 | positive regulation of DNA-templated transcription, elongation (GO:0032786) | 3.67349164 |
| 54 | synaptonemal complex assembly (GO:0007130) | 3.66023875 |
| 55 | amino-acid betaine metabolic process (GO:0006577) | 3.61910348 |
| 56 | rRNA methylation (GO:0031167) | 3.57527550 |
| 57 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 3.57022965 |
| 58 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 3.57022965 |
| 59 | positive regulation of digestive system process (GO:0060456) | 3.49710479 |
| 60 | exogenous drug catabolic process (GO:0042738) | 3.49415784 |
| 61 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.49406086 |
| 62 | regulation of meiosis I (GO:0060631) | 3.46618593 |
| 63 | protein K63-linked deubiquitination (GO:0070536) | 3.44301269 |
| 64 | carnitine transmembrane transport (GO:1902603) | 3.43599396 |
| 65 | autophagic vacuole assembly (GO:0000045) | 3.43390352 |
| 66 | negative regulation of fatty acid metabolic process (GO:0045922) | 3.43241877 |
| 67 | purine nucleobase biosynthetic process (GO:0009113) | 3.40642515 |
| 68 | cellular protein catabolic process (GO:0044257) | 3.37784355 |
| 69 | protein K48-linked deubiquitination (GO:0071108) | 3.36827862 |
| 70 | Golgi to endosome transport (GO:0006895) | 3.32496030 |
| 71 | peptidyl-lysine methylation (GO:0018022) | 3.28875779 |
| 72 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 3.28829047 |
| 73 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 3.25528401 |
| 74 | synaptonemal complex organization (GO:0070193) | 3.20580730 |
| 75 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.17896323 |
| 76 | carnitine transport (GO:0015879) | 3.17142112 |
| 77 | amino-acid betaine transport (GO:0015838) | 3.17142112 |
| 78 | nucleobase biosynthetic process (GO:0046112) | 3.16546648 |
| 79 | positive regulation of fatty acid oxidation (GO:0046321) | 3.15647059 |
| 80 | regulation of mitochondrial fission (GO:0090140) | 3.13757565 |
| 81 | positive regulation of systemic arterial blood pressure (GO:0003084) | 3.13154658 |
| 82 | tryptophan metabolic process (GO:0006568) | 3.12980539 |
| 83 | regulation of histone H3-K4 methylation (GO:0051569) | 3.09859604 |
| 84 | telencephalon development (GO:0021537) | 3.08890477 |
| 85 | negative regulation of Rho protein signal transduction (GO:0035024) | 3.08574717 |
| 86 | N-acetylglucosamine metabolic process (GO:0006044) | 3.07918263 |
| 87 | temperature homeostasis (GO:0001659) | 3.01840896 |
| 88 | negative regulation of meiosis (GO:0045835) | 3.01027371 |
| 89 | drug catabolic process (GO:0042737) | 3.00509982 |
| 90 | regulation of protein kinase A signaling (GO:0010738) | 2.98334473 |
| 91 | fatty acid transmembrane transport (GO:1902001) | 2.94087588 |
| 92 | negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124) | 2.92758662 |
| 93 | toxin transport (GO:1901998) | 2.90325111 |
| 94 | positive regulation of dendritic spine development (GO:0060999) | 2.89889875 |
| 95 | positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261) | 2.89551560 |
| 96 | rRNA modification (GO:0000154) | 2.89179574 |
| 97 | regulation of synapse structural plasticity (GO:0051823) | 2.89134376 |
| 98 | histone H3-K4 methylation (GO:0051568) | 2.84536469 |
| 99 | meiotic chromosome segregation (GO:0045132) | 11.9837509 |
| 100 | snRNA processing (GO:0016180) | 10.1022147 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 3.84862466 |
| 2 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.24502551 |
| 3 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.14479832 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.09707958 |
| 5 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.85102874 |
| 6 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.83606609 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.67403710 |
| 8 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.59995493 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.52923007 |
| 10 | EWS_26573619_Chip-Seq_HEK293_Human | 2.43622821 |
| 11 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.20077466 |
| 12 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 2.01738902 |
| 13 | TCF4_23295773_ChIP-Seq_U87_Human | 1.86460090 |
| 14 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.84209755 |
| 15 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.84200077 |
| 16 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.79470330 |
| 17 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.77984621 |
| 18 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.71342440 |
| 19 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.67559931 |
| 20 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.64928547 |
| 21 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.64334146 |
| 22 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.64231238 |
| 23 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.63514875 |
| 24 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.63514875 |
| 25 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63492560 |
| 26 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.62508639 |
| 27 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.60743099 |
| 28 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.60136996 |
| 29 | CJUN_26792858_Chip-Seq_BT549_Human | 1.59865759 |
| 30 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.58779853 |
| 31 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.57742920 |
| 32 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.57742920 |
| 33 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.53652772 |
| 34 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.52513804 |
| 35 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.52093002 |
| 36 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.52005813 |
| 37 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.49171992 |
| 38 | AR_20517297_ChIP-Seq_VCAP_Human | 1.47051459 |
| 39 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.44642681 |
| 40 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.44617198 |
| 41 | FUS_26573619_Chip-Seq_HEK293_Human | 1.43753834 |
| 42 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.43411807 |
| 43 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.42423516 |
| 44 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.41590151 |
| 45 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.37028581 |
| 46 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.36590809 |
| 47 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.35212423 |
| 48 | RBPJ_21746931_ChIP-Seq_IB4_Human | 1.31372652 |
| 49 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.31355549 |
| 50 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.30963406 |
| 51 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.30963406 |
| 52 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 1.30624808 |
| 53 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.28092325 |
| 54 | ETV1_20927104_ChIP-Seq_GIST48_Human | 1.27365981 |
| 55 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.26475719 |
| 56 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.25881193 |
| 57 | GF1_26923725_Chip-Seq_HPCs_Mouse | 1.25399180 |
| 58 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.20420821 |
| 59 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.20191766 |
| 60 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.19808091 |
| 61 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.19722922 |
| 62 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.19038860 |
| 63 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.18889016 |
| 64 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.17593635 |
| 65 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.16338804 |
| 66 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.15909904 |
| 67 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.15281554 |
| 68 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.14404347 |
| 69 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.14292269 |
| 70 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 1.13913550 |
| 71 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.13897261 |
| 72 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.12831267 |
| 73 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.12222383 |
| 74 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.11586811 |
| 75 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.10841564 |
| 76 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.10610870 |
| 77 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.10540806 |
| 78 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.10042865 |
| 79 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.09664590 |
| 80 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 1.09375876 |
| 81 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.08575893 |
| 82 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.08106384 |
| 83 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.06854090 |
| 84 | P300_19829295_ChIP-Seq_ESCs_Human | 1.05763352 |
| 85 | VDR_22108803_ChIP-Seq_LS180_Human | 1.05438360 |
| 86 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.05339155 |
| 87 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.04790300 |
| 88 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.04125366 |
| 89 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.03788318 |
| 90 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03381441 |
| 91 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.03266760 |
| 92 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.00567456 |
| 93 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.00127161 |
| 94 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.97587863 |
| 95 | GATA3_26560356_Chip-Seq_TH1_Human | 0.96831103 |
| 96 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.95486651 |
| 97 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.95423380 |
| 98 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.95334124 |
| 99 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.95041037 |
| 100 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.94361565 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005310_abnormal_salivary_gland | 5.35416281 |
| 2 | MP0004484_altered_response_of | 4.45629429 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 3.95986893 |
| 4 | MP0005646_abnormal_pituitary_gland | 3.68864027 |
| 5 | MP0001986_abnormal_taste_sensitivity | 3.29926788 |
| 6 | MP0005167_abnormal_blood-brain_barrier | 3.19974300 |
| 7 | MP0009764_decreased_sensitivity_to | 3.11008817 |
| 8 | MP0009780_abnormal_chondrocyte_physiolo | 2.78203121 |
| 9 | MP0003195_calcinosis | 2.76170564 |
| 10 | MP0006072_abnormal_retinal_apoptosis | 2.72682044 |
| 11 | MP0003011_delayed_dark_adaptation | 2.67611073 |
| 12 | MP0003646_muscle_fatigue | 2.65075813 |
| 13 | MP0005365_abnormal_bile_salt | 2.56979965 |
| 14 | MP0002876_abnormal_thyroid_physiology | 2.39053562 |
| 15 | MP0002138_abnormal_hepatobiliary_system | 2.30947124 |
| 16 | MP0008875_abnormal_xenobiotic_pharmacok | 2.22222127 |
| 17 | MP0009643_abnormal_urine_homeostasis | 2.13316667 |
| 18 | MP0005360_urolithiasis | 1.99763507 |
| 19 | MP0004215_abnormal_myocardial_fiber | 1.91653280 |
| 20 | MP0005551_abnormal_eye_electrophysiolog | 1.83375563 |
| 21 | MP0004742_abnormal_vestibular_system | 1.81178131 |
| 22 | MP0008872_abnormal_physiological_respon | 1.80763038 |
| 23 | MP0005253_abnormal_eye_physiology | 1.78041914 |
| 24 | MP0004130_abnormal_muscle_cell | 1.73849665 |
| 25 | MP0005332_abnormal_amino_acid | 1.73012147 |
| 26 | MP0004084_abnormal_cardiac_muscle | 1.65718293 |
| 27 | MP0001764_abnormal_homeostasis | 1.64695048 |
| 28 | MP0002693_abnormal_pancreas_physiology | 1.61678928 |
| 29 | MP0009745_abnormal_behavioral_response | 1.61430413 |
| 30 | MP0005165_increased_susceptibility_to | 1.55192039 |
| 31 | MP0008775_abnormal_heart_ventricle | 1.53808516 |
| 32 | MP0003136_yellow_coat_color | 1.51227137 |
| 33 | MP0004043_abnormal_pH_regulation | 1.48749195 |
| 34 | MP0004885_abnormal_endolymph | 1.48061478 |
| 35 | MP0004883_abnormal_blood_vessel | 1.47706865 |
| 36 | MP0003221_abnormal_cardiomyocyte_apopto | 1.45412009 |
| 37 | MP0002127_abnormal_cardiovascular_syste | 1.44222264 |
| 38 | MP0005410_abnormal_fertilization | 1.43324082 |
| 39 | MP0003045_fibrosis | 1.42820412 |
| 40 | MP0005423_abnormal_somatic_nervous | 1.42448162 |
| 41 | MP0004782_abnormal_surfactant_physiolog | 1.37669731 |
| 42 | MP0001348_abnormal_lacrimal_gland | 1.23436591 |
| 43 | MP0002928_abnormal_bile_duct | 1.19051776 |
| 44 | MP0001324_abnormal_eye_pigmentation | 1.17882046 |
| 45 | MP0001756_abnormal_urination | 1.14339991 |
| 46 | MP0000631_abnormal_neuroendocrine_gland | 1.13129983 |
| 47 | MP0003718_maternal_effect | 1.12085505 |
| 48 | MP0002136_abnormal_kidney_physiology | 1.11165270 |
| 49 | MP0001501_abnormal_sleep_pattern | 1.10224720 |
| 50 | MP0008469_abnormal_protein_level | 1.06824204 |
| 51 | MP0004233_abnormal_muscle_weight | 1.02499437 |
| 52 | MP0004085_abnormal_heartbeat | 1.01092085 |
| 53 | MP0005647_abnormal_sex_gland | 1.00816813 |
| 54 | MP0003879_abnormal_hair_cell | 1.00060959 |
| 55 | MP0002168_other_aberrant_phenotype | 0.96429699 |
| 56 | MP0010329_abnormal_lipoprotein_level | 0.96158827 |
| 57 | MP0005164_abnormal_response_to | 0.95216915 |
| 58 | MP0001666_abnormal_nutrient_absorption | 0.95173271 |
| 59 | MP0000383_abnormal_hair_follicle | 0.92929141 |
| 60 | MP0000230_abnormal_systemic_arterial | 0.92776108 |
| 61 | MP0000427_abnormal_hair_cycle | 0.91273623 |
| 62 | MP0003638_abnormal_response/metabolism_ | 0.91254645 |
| 63 | MP0001970_abnormal_pain_threshold | 0.90805457 |
| 64 | MP0005330_cardiomyopathy | 0.89869574 |
| 65 | MP0010368_abnormal_lymphatic_system | 0.88250685 |
| 66 | MP0008877_abnormal_DNA_methylation | 0.86641962 |
| 67 | MP0002837_dystrophic_cardiac_calcinosis | 0.85436004 |
| 68 | MP0002089_abnormal_postnatal_growth/wei | 0.84393659 |
| 69 | MP0001502_abnormal_circadian_rhythm | 0.83569202 |
| 70 | MP0005376_homeostasis/metabolism_phenot | 0.82961816 |
| 71 | MP0005395_other_phenotype | 0.82669552 |
| 72 | MP0002118_abnormal_lipid_homeostasis | 0.82486449 |
| 73 | MP0000372_irregular_coat_pigmentation | 0.81788196 |
| 74 | MP0002557_abnormal_social/conspecific_i | 0.81004458 |
| 75 | MP0001765_abnormal_ion_homeostasis | 0.80949495 |
| 76 | MP0002078_abnormal_glucose_homeostasis | 0.80266122 |
| 77 | MP0005409_darkened_coat_color | 0.80199748 |
| 78 | MP0002733_abnormal_thermal_nociception | 0.78968270 |
| 79 | MP0000609_abnormal_liver_physiology | 0.78546563 |
| 80 | MP0003868_abnormal_feces_composition | 0.77946669 |
| 81 | MP0001958_emphysema | 0.77379074 |
| 82 | MP0002723_abnormal_immune_serum | 0.77333648 |
| 83 | MP0005448_abnormal_energy_balance | 0.77089115 |
| 84 | MP0005645_abnormal_hypothalamus_physiol | 0.75445604 |
| 85 | MP0005220_abnormal_exocrine_pancreas | 0.75276275 |
| 86 | MP0001800_abnormal_humoral_immune | 0.73449820 |
| 87 | MP0004381_abnormal_hair_follicle | 0.73118552 |
| 88 | MP0004036_abnormal_muscle_relaxation | 0.71217511 |
| 89 | MP0001845_abnormal_inflammatory_respons | 0.70569286 |
| 90 | MP0006054_spinal_hemorrhage | 0.69994787 |
| 91 | MP0000249_abnormal_blood_vessel | 0.69486506 |
| 92 | MP0005000_abnormal_immune_tolerance | 0.69422205 |
| 93 | MP0002139_abnormal_hepatobiliary_system | 0.66596488 |
| 94 | MP0002254_reproductive_system_inflammat | 0.63569638 |
| 95 | MP0009697_abnormal_copulation | 0.63511852 |
| 96 | MP0002972_abnormal_cardiac_muscle | 0.62370129 |
| 97 | MP0005595_abnormal_vascular_smooth | 0.62031357 |
| 98 | MP0002075_abnormal_coat/hair_pigmentati | 0.59567775 |
| 99 | MP0002064_seizures | 0.58685240 |
| 100 | MP0002210_abnormal_sex_determination | 0.57440988 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Decreased circulating renin level (HP:0003351) | 9.23816959 |
| 2 | Pigmentary retinal degeneration (HP:0001146) | 6.78472453 |
| 3 | Polydipsia (HP:0001959) | 5.67789973 |
| 4 | Abnormal drinking behavior (HP:0030082) | 5.67789973 |
| 5 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 5.67773802 |
| 6 | Chronic bronchitis (HP:0004469) | 5.55714959 |
| 7 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 5.11065742 |
| 8 | Abnormality of renin-angiotensin system (HP:0000847) | 5.08263343 |
| 9 | Choroideremia (HP:0001139) | 4.79668934 |
| 10 | Abnormal rod and cone electroretinograms (HP:0008323) | 4.73933590 |
| 11 | Flat occiput (HP:0005469) | 4.64295303 |
| 12 | Decreased central vision (HP:0007663) | 4.15668009 |
| 13 | Polyuria (HP:0000103) | 4.03093867 |
| 14 | Attenuation of retinal blood vessels (HP:0007843) | 3.99535986 |
| 15 | Thyroid-stimulating hormone excess (HP:0002925) | 3.62159533 |
| 16 | Hyperkalemia (HP:0002153) | 3.60849167 |
| 17 | Bony spicule pigmentary retinopathy (HP:0007737) | 3.46321848 |
| 18 | Abnormal urine output (HP:0012590) | 3.39627984 |
| 19 | Abnormality of incisor morphology (HP:0011063) | 3.32174935 |
| 20 | Rimmed vacuoles (HP:0003805) | 3.25115033 |
| 21 | Conical tooth (HP:0000698) | 3.21571031 |
| 22 | Recurrent otitis media (HP:0000403) | 3.18989521 |
| 23 | Severe Myopia (HP:0011003) | 3.12288426 |
| 24 | Long toe (HP:0010511) | 3.01607225 |
| 25 | Biliary tract neoplasm (HP:0100574) | 2.98332310 |
| 26 | Bile duct proliferation (HP:0001408) | 2.96118817 |
| 27 | Abnormal biliary tract physiology (HP:0012439) | 2.96118817 |
| 28 | Hypokalemic alkalosis (HP:0001949) | 2.94334648 |
| 29 | Hypoplastic nipples (HP:0002557) | 2.88820957 |
| 30 | Bronchitis (HP:0012387) | 2.86507366 |
| 31 | Abnormality of renal excretion (HP:0011036) | 2.84156217 |
| 32 | Hyponatremia (HP:0002902) | 2.82464940 |
| 33 | Congenital stationary night blindness (HP:0007642) | 2.74846110 |
| 34 | Abnormality of alanine metabolism (HP:0010916) | 2.69881221 |
| 35 | Hyperalaninemia (HP:0003348) | 2.69881221 |
| 36 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.69881221 |
| 37 | Hypocalcemia (HP:0002901) | 2.66383832 |
| 38 | Pancreatic cysts (HP:0001737) | 2.61452014 |
| 39 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.60881128 |
| 40 | Hyperactive renin-angiotensin system (HP:0000841) | 2.58671289 |
| 41 | True hermaphroditism (HP:0010459) | 2.56997599 |
| 42 | Limb-girdle muscle atrophy (HP:0003797) | 2.55271324 |
| 43 | Sleep apnea (HP:0010535) | 2.49016018 |
| 44 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.45487865 |
| 45 | Chronic hepatic failure (HP:0100626) | 2.44193556 |
| 46 | Hyperaldosteronism (HP:0000859) | 2.42583723 |
| 47 | Abnormality of sodium homeostasis (HP:0010931) | 2.42503740 |
| 48 | 2-3 toe syndactyly (HP:0004691) | 2.41758316 |
| 49 | Abnormality of chloride homeostasis (HP:0011422) | 2.34919969 |
| 50 | Broad-based gait (HP:0002136) | 2.21456363 |
| 51 | Retrobulbar optic neuritis (HP:0100654) | 2.20270391 |
| 52 | Optic neuritis (HP:0100653) | 2.20270391 |
| 53 | Pancreatic fibrosis (HP:0100732) | 2.16974301 |
| 54 | Molar tooth sign on MRI (HP:0002419) | 2.14139306 |
| 55 | Abnormality of midbrain morphology (HP:0002418) | 2.14139306 |
| 56 | Gaze-evoked nystagmus (HP:0000640) | 2.13488899 |
| 57 | Rhinitis (HP:0012384) | 2.11847107 |
| 58 | Neoplasm of the heart (HP:0100544) | 2.09799415 |
| 59 | Ketoacidosis (HP:0001993) | 2.06939168 |
| 60 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.06501305 |
| 61 | Hypoplasia of the fovea (HP:0007750) | 2.06501305 |
| 62 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.06063490 |
| 63 | Retinitis pigmentosa (HP:0000510) | 2.04335950 |
| 64 | Orchitis (HP:0100796) | 2.04304698 |
| 65 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.03942007 |
| 66 | Abnormality of T cell physiology (HP:0011840) | 2.01414983 |
| 67 | Clumsiness (HP:0002312) | 2.01007741 |
| 68 | Abnormality of potassium homeostasis (HP:0011042) | 1.96027500 |
| 69 | Skin nodule (HP:0200036) | 1.92943599 |
| 70 | Abnormality of the pons (HP:0007361) | 1.91387344 |
| 71 | Increased cerebral lipofuscin (HP:0011813) | 1.89933681 |
| 72 | Photophobia (HP:0000613) | 1.89026052 |
| 73 | Renal salt wasting (HP:0000127) | 1.88422230 |
| 74 | Portal hypertension (HP:0001409) | 1.87104186 |
| 75 | Central scotoma (HP:0000603) | 1.86925104 |
| 76 | Ketosis (HP:0001946) | 1.85369081 |
| 77 | Abnormality of the renal cortex (HP:0011035) | 1.84268820 |
| 78 | Congenital hepatic fibrosis (HP:0002612) | 1.84179020 |
| 79 | Type II lissencephaly (HP:0007260) | 1.83914445 |
| 80 | Abnormal biliary tract morphology (HP:0012440) | 1.83720866 |
| 81 | Gonadal dysgenesis (HP:0000133) | 1.83028001 |
| 82 | Intrahepatic cholestasis (HP:0001406) | 1.81913754 |
| 83 | Myositis (HP:0100614) | 1.80998616 |
| 84 | Tubular atrophy (HP:0000092) | 1.80279303 |
| 85 | Hypomagnesemia (HP:0002917) | 1.80188440 |
| 86 | Hemoptysis (HP:0002105) | 1.79451225 |
| 87 | Focal seizures (HP:0007359) | 1.78665064 |
| 88 | Type II diabetes mellitus (HP:0005978) | 1.77855026 |
| 89 | Hypoplasia of the uterus (HP:0000013) | 1.77169386 |
| 90 | Abnormality of proline metabolism (HP:0010907) | 1.76957183 |
| 91 | Hydroxyprolinuria (HP:0003080) | 1.76957183 |
| 92 | Hypoplasia of the pons (HP:0012110) | 1.76827942 |
| 93 | Ependymoma (HP:0002888) | 1.76631457 |
| 94 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.76169061 |
| 95 | Abnormality of the nasal septum (HP:0000419) | 1.75418858 |
| 96 | Bronchiectasis (HP:0002110) | 1.74204303 |
| 97 | Cerebellar dysplasia (HP:0007033) | 1.72480616 |
| 98 | Neoplasm of the rectum (HP:0100743) | 1.70301776 |
| 99 | Hypokalemia (HP:0002900) | 1.69354981 |
| 100 | Syncope (HP:0001279) | 1.67415483 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K9 | 4.53853053 |
| 2 | CAMKK2 | 4.21323436 |
| 3 | FRK | 4.14084116 |
| 4 | CAMK1D | 3.58899455 |
| 5 | CAMK1G | 2.37124614 |
| 6 | PDK1 | 2.14851488 |
| 7 | PDPK1 | 2.06763042 |
| 8 | BLK | 11.3793405 |
| 9 | CAMK4 | 1.74107443 |
| 10 | EPHA4 | 1.69669307 |
| 11 | ZAK | 1.62517447 |
| 12 | HIPK2 | 1.53066185 |
| 13 | TXK | 1.52521867 |
| 14 | TNK2 | 1.47070536 |
| 15 | CAMKK1 | 1.34907791 |
| 16 | WNK4 | 1.31910663 |
| 17 | STK38L | 1.19017707 |
| 18 | RPS6KA4 | 1.15633567 |
| 19 | MAPKAPK5 | 1.10541714 |
| 20 | DYRK3 | 1.00896883 |
| 21 | STK39 | 0.94934323 |
| 22 | TLK1 | 0.90105397 |
| 23 | MELK | 0.89104218 |
| 24 | PINK1 | 0.86503027 |
| 25 | DAPK2 | 0.82556619 |
| 26 | OXSR1 | 0.82055265 |
| 27 | ADRBK2 | 0.79617334 |
| 28 | NUAK1 | 0.76984664 |
| 29 | MARK3 | 0.76953272 |
| 30 | MAPKAPK3 | 0.72264830 |
| 31 | PTK2B | 0.70721766 |
| 32 | EPHA3 | 0.68070326 |
| 33 | GRK5 | 0.65334155 |
| 34 | PRKCE | 0.60994478 |
| 35 | MAP4K2 | 0.60605675 |
| 36 | SRPK1 | 0.60390789 |
| 37 | RPS6KA6 | 0.59567822 |
| 38 | PRKAA2 | 0.58794694 |
| 39 | SGK2 | 0.57188762 |
| 40 | BMX | 0.55473432 |
| 41 | PRKD1 | 0.54256321 |
| 42 | CAMK1 | 0.53852075 |
| 43 | GRK1 | 0.51764867 |
| 44 | ERBB2 | 0.51625723 |
| 45 | BRD4 | 0.51567035 |
| 46 | GRK7 | 0.50821191 |
| 47 | GSK3A | 0.50708090 |
| 48 | IKBKB | 0.49920413 |
| 49 | LYN | 0.48362568 |
| 50 | CSNK1E | 0.47540210 |
| 51 | JAK3 | 0.47246308 |
| 52 | STK38 | 0.47220573 |
| 53 | ADRBK1 | 0.46263294 |
| 54 | CDK9 | 0.45856987 |
| 55 | ROCK1 | 0.43393053 |
| 56 | TGFBR2 | 0.43281717 |
| 57 | PRKCI | 0.43276731 |
| 58 | KSR1 | 0.42949030 |
| 59 | DYRK2 | 0.42484516 |
| 60 | NEK2 | 0.42200519 |
| 61 | TRPM7 | 0.42146917 |
| 62 | ITK | 0.41772730 |
| 63 | RPS6KL1 | 0.41501072 |
| 64 | RPS6KC1 | 0.41501072 |
| 65 | SGK1 | 0.40213963 |
| 66 | ACVR1B | 0.39622942 |
| 67 | FER | 0.39359466 |
| 68 | PDGFRB | 0.38098453 |
| 69 | RPS6KA2 | 0.38043490 |
| 70 | MAP3K5 | 0.37959591 |
| 71 | PRKG2 | 0.37512500 |
| 72 | KIT | 0.35809199 |
| 73 | RPS6KA5 | 0.34768314 |
| 74 | WNK1 | 0.34628412 |
| 75 | PKN1 | 0.33381975 |
| 76 | TAOK3 | 0.33170284 |
| 77 | MYLK | 0.32388169 |
| 78 | MAP3K4 | 0.30962518 |
| 79 | STK11 | 0.29546193 |
| 80 | STK3 | 0.27289272 |
| 81 | PRKCZ | 0.26172238 |
| 82 | PRKCQ | 0.24140027 |
| 83 | PRKD2 | 0.24088807 |
| 84 | SGK494 | 0.23832374 |
| 85 | SGK223 | 0.23832374 |
| 86 | ABL1 | 0.23264907 |
| 87 | CAMK2D | 0.23126982 |
| 88 | PRKG1 | 0.22054608 |
| 89 | JAK1 | 0.21975270 |
| 90 | PAK3 | 0.21869938 |
| 91 | WNK3 | 0.21793777 |
| 92 | LATS1 | 0.21094793 |
| 93 | CAMK2A | 0.20221820 |
| 94 | SGK3 | 0.19970304 |
| 95 | PRKAA1 | 0.19501574 |
| 96 | NLK | 0.18851422 |
| 97 | MAP2K6 | 0.18789968 |
| 98 | MAPK7 | 0.18531443 |
| 99 | EPHB2 | 0.18314534 |
| 100 | RPS6KA3 | 0.18073729 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Regulation of autophagy_Homo sapiens_hsa04140 | 5.05964574 |
| 2 | Caffeine metabolism_Homo sapiens_hsa00232 | 4.01210020 |
| 3 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 3.89024764 |
| 4 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 3.58516806 |
| 5 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.28025460 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.53075857 |
| 7 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.46388289 |
| 8 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 2.31490379 |
| 9 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.21837927 |
| 10 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.16491690 |
| 11 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.14329632 |
| 12 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.02598183 |
| 13 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.92872594 |
| 14 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.91749223 |
| 15 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.84505173 |
| 16 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.69834337 |
| 17 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.59626590 |
| 18 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.58347312 |
| 19 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.57149150 |
| 20 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.42558350 |
| 21 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.39525602 |
| 22 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.37120779 |
| 23 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.30651011 |
| 24 | Asthma_Homo sapiens_hsa05310 | 1.26605923 |
| 25 | Lysine degradation_Homo sapiens_hsa00310 | 1.26218505 |
| 26 | Morphine addiction_Homo sapiens_hsa05032 | 1.23811240 |
| 27 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.11965579 |
| 28 | Sulfur relay system_Homo sapiens_hsa04122 | 1.11627833 |
| 29 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.10715352 |
| 30 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.08647959 |
| 31 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.04571809 |
| 32 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.00037636 |
| 33 | Allograft rejection_Homo sapiens_hsa05330 | 0.99408461 |
| 34 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.90310563 |
| 35 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.89770881 |
| 36 | Taste transduction_Homo sapiens_hsa04742 | 0.88162552 |
| 37 | Phototransduction_Homo sapiens_hsa04744 | 0.87841707 |
| 38 | Insulin secretion_Homo sapiens_hsa04911 | 0.87493348 |
| 39 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.85526577 |
| 40 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.80726491 |
| 41 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.80265261 |
| 42 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.79367217 |
| 43 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.77995266 |
| 44 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.76613623 |
| 45 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.76502534 |
| 46 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.76470811 |
| 47 | Retinol metabolism_Homo sapiens_hsa00830 | 0.72496628 |
| 48 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.68844178 |
| 49 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.68222443 |
| 50 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.68159860 |
| 51 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.66756473 |
| 52 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.66594521 |
| 53 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.65651610 |
| 54 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.65560431 |
| 55 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.65520531 |
| 56 | Renin secretion_Homo sapiens_hsa04924 | 0.64597247 |
| 57 | Insulin resistance_Homo sapiens_hsa04931 | 0.64326880 |
| 58 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.64247390 |
| 59 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.63290552 |
| 60 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.63136600 |
| 61 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.61857840 |
| 62 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.60930895 |
| 63 | Circadian rhythm_Homo sapiens_hsa04710 | 0.60740271 |
| 64 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.60402574 |
| 65 | Bile secretion_Homo sapiens_hsa04976 | 0.58935469 |
| 66 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.57085879 |
| 67 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.56344416 |
| 68 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.54421633 |
| 69 | Nicotine addiction_Homo sapiens_hsa05033 | 0.53178921 |
| 70 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.52856492 |
| 71 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.52522763 |
| 72 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.50764057 |
| 73 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.48757222 |
| 74 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.47476893 |
| 75 | GABAergic synapse_Homo sapiens_hsa04727 | 0.47270071 |
| 76 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.47150585 |
| 77 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.46909870 |
| 78 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.45754915 |
| 79 | Mineral absorption_Homo sapiens_hsa04978 | 0.45489415 |
| 80 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.45315941 |
| 81 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.44477718 |
| 82 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.44208318 |
| 83 | Salivary secretion_Homo sapiens_hsa04970 | 0.44200574 |
| 84 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.42824211 |
| 85 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.42565307 |
| 86 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.42000111 |
| 87 | Salmonella infection_Homo sapiens_hsa05132 | 0.41744219 |
| 88 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.41040253 |
| 89 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.39965174 |
| 90 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.39471244 |
| 91 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.39004634 |
| 92 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.38491533 |
| 93 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.38072230 |
| 94 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.36176415 |
| 95 | Histidine metabolism_Homo sapiens_hsa00340 | 0.34995972 |
| 96 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.34602605 |
| 97 | Circadian entrainment_Homo sapiens_hsa04713 | 0.33945355 |
| 98 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.33120913 |
| 99 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.31348019 |
| 100 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.30608045 |

